menu
    • menu

    Company profile for Sebela Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women’s Health. Founded in 1983 in Braintree, Massachusetts, Braintree Laboratories has been committed to expanding the universe of colonoscopy preparation products for almost 40 years. Braintree is a specialty pharmaceutical company that develops, manufactures, and markets these products in...
    Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women’s Health. Founded in 1983 in Braintree, Massachusetts, Braintree Laboratories has been committed to expanding the universe of colonoscopy preparation products for almost 40 years. Braintree is a specialty pharmaceutical company that develops, manufactures, and markets these products in the field of Gastroenterology. In May 2018, Sebela Pharmaceuticals acquired Braintree Laboratories. It created a path for significant growth focusing on Sebela’s core therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sebela PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    645 Hembree Parkway, Suite I Roswell, GA 30076
    Telephone
    Telephone
    +1 844-732-3521
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sebelapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MIUDELLA Copper IUS Ph 3 Data Wins Outstanding Article Award
    MIUDELLA Copper IUS Ph 3 Data Wins Outstanding Article Award

    27 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/miudella-hormone-free-copper-intrauterine-system-ius-phase-3-data-publication-in-contraception-honored-with-daniel-mishell-jr-md-outstanding-article-award-at-society-of-family-planning-annual-meeting-302594700.html

    PR NEWSWIRE
    27 Oct 2025
    Share Share
    Sebela Women's Health's MIUDELLA® (IUS) Named To Time's List
    Sebela Women's Health's MIUDELLA® (IUS) Named To Time's List

    15 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-womens-healths-miudella-hormone-free-copper-intrauterine-system-ius-named-to-times-list-of-the-best-inventions-of-2025-302585432.html

    PR NEWSWIRE
    15 Oct 2025
    Share Share
    Sebela Pharmaceuticals® Completes Phase 3 TRIUMpH Program
    Sebela Pharmaceuticals® Completes Phase 3 TRIUMpH Program

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-successful-completion-of-phase-3-triumph-program-of-tegoprazan-in-gerd-with-positive-24-week-maintenance-phase-results-302524332.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    Sebela Pharma Reports Positive Phase 3 Tegoprazan Result in GERD
    Sebela Pharma Reports Positive Phase 3 Tegoprazan Result in GERD

    23 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-positive-topline-results-from-phase-3-triumph-program-of-tegoprazan-in-gerd-302435337.html

    PR NEWSWIRE
    23 Apr 2025
    Share Share
    FDA Approves MIUDELLA®, First Hormone-Free Copper IUS in U.S.
    FDA Approves MIUDELLA®, First Hormone-Free Copper IUS in U.S.

    25 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/fda-approves-miudella-the-first-hormone-free-copper-intrauterine-system-ius-in-the-us-in-over-40-years-from-sebela-womens-health-inc-302384684.html

    PR NEWSWIRE
    25 Feb 2025
    Share Share
    Sebela's Ph 3 For Copper 175 mm² IUD Published In Contraception
    Sebela's Ph 3 For Copper 175 mm² IUD Published In Contraception

    24 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-womens-health-announces-publication-of-phase-3-pivotal-study-results-for-the-investigational-copper-175-mm2-intrauterine-device-iud-in-contraception-302359611.html

    PR NEWSWIRE
    24 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search